Biogen (BIIB) Reports Strategic Collaboration with C4 Therapeutics to Discover and Develop Potential New Treatments for Neurological Conditions

January 4, 2019 7:31 AM
Biogen Inc (NASDAQ: BIIB) and C4 Therapeutics (C4T) announced today that they have entered into a strategic collaboration to investigate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments

Next Articles